NCT00199394View on ClinicalTrials.gov

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

November 30, 2005

Conditions
Parkinson's Disease
Interventions
DRUG

Istradefylline (KW-6002)

Trial Locations (1)

SL14 DX

Kyowa Hakko UK Ltd., Slough

Sponsors
All Listed Sponsors
collaborator

Kyowa Hakko Kirin UK, Ltd.

INDUSTRY

lead

Kyowa Kirin Co., Ltd.

INDUSTRY